Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

COVID-19 infection can significantly cause temporary hair loss.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Some drugs may help treat both COVID-19 and radiation injury.

COVID-19 may trigger sudden temporary hair loss.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

Long COVID is a big health problem needing more research and better treatments.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Allogenic ASCs and ECM transplants are safe and effective for tissue regeneration.

Proper mTOR signaling is crucial for healthy skin and preventing skin diseases.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Damaged skin has a weakened barrier, making it more vulnerable to substances and inflammation.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Mesenchymal stem cells could help treat diabetes and its complications by improving insulin function and reducing inflammation.

South African wild foods may help prevent cardiovascular disease.

Researchers converted human embryonic stem cells into trophoblast stem cells using specific transcription factors.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.